Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecasin plus standard Riluzole therapy in ALS (Phase 2b, randomized parallel trial)
KCT0003792Phase 2Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mecasin, riluzole in amyotrophic lateral sclerosis (ALS), sponsored by Ministry of Health & Welfare. Started Jan 2019; status: recruiting.
02
Drugs
Mecasinriluzole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on KCT0003792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003792.